Mirae Asset Global Etfs Holdings Ltd. Axogen, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Axogen, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 21,151 shares of AXGN stock, worth $307,958. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,151Holding current value
$307,958% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AXGN
# of Institutions
129Shares Held
35.8MCall Options Held
79.1KPut Options Held
500-
Arrow Mark Colorado Holdings LLC Denver, CO5.12MShares$74.5 Million0.49% of portfolio
-
First Light Asset Management, LLC Edina, MN3.34MShares$48.7 Million2.2% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.31MShares$48.1 Million2.42% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$47.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.52MShares$36.7 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $616M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...